---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035233"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-07-29T21:12:42+00:00"
generated_at: "2026-07-29T21:14:19.656119+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics prices $1.6M private placement of units with pre-funded and common warrants

## Summary
- Issued 618,682 units at $2.585 per unit; includes 218,682 shares and 400,000 pre-funded warrants.
- Gross proceeds of $1.6M; net proceeds for clinical trials (HCW9302, HCW11-018b, HCW11-040) and working capital.
- CEO Hing C. Wong, Chairman Scott Garrett, and SVP Lee Flowers participated on same terms as other investors.
- Common warrants for up to 618,682 shares require stockholder approval under Nasdaq Rule 5635(d).
- Pre-funded warrants exercisable at $0.0001; common warrants at $2.585, expire 5.5 years from issuance.

## SEC filing metadata
- accession: 0001493152-26-035233
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-07-29T21:12:42+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226035233/0001493152-26-035233-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226035233/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035233
- JSON: https://secwatch.observer/filing/0001493152-26-035233.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035233.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.